Petrukhin, Konstantin
Chapter History
First Online: 24 July 2020
Compliance with Ethical Standards
:
: The author is an inventor on patent applications for RBP4 antagonists discussed in this manuscript. The patent applications are assigned to Columbia University, and the author may benefit from licensing agreements between Columbia University and outside parties in relation to these patent applications.
: This manuscript is a review of previously published accounts, as such no animal or human studies were performed.
: This study was funded by the NIH grant R01EY028549. This study was supported by NIH Grants P30 EY019007 (Core Support for Vision Research), and unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, Columbia University.
: This article does not contain any studies with human participants performed by the author.